InsiderClue
Insiders · Profile

PAPADOPOULOS STELIOS

Director at EXELIXIS · Director at Biogen. Filing since 30 Oct 2008. CIK 0001202098

EXEL EXELIXIS, INC. Director · 15 trades BIIB Biogen Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
EXEL EXELIXIS, INC.
12 Nov 2025
Director
Sold at will
100,000
$4.36M
7.8%
EXEL EXELIXIS, INC.
15 May 2025
Director
Sold at will
36,508
$1.62M
2.8%
EXEL EXELIXIS, INC.
20 May 2024
Director
Sold at will
11,437
$240.18K
0.9%
EXEL EXELIXIS, INC.
22 Feb 2022
Director
Sold, plan not stated
84,515
$1.65M
6.5%
EXEL EXELIXIS, INC.
11 May 2021
Director
Sold, plan not stated
20,770
$518.79K
1.7%
EXEL EXELIXIS, INC.
8 May 2020
Director
Sold, plan not stated
45,000
$1.16M
4.1%
EXEL EXELIXIS, INC.
21 Feb 2019
Director
Sold, plan not stated
26,250
$557.81K
2.5%
EXEL EXELIXIS, INC.
7 May 2018
Director
Sold, plan not stated
15,000
$332.25K
1.4%
EXEL EXELIXIS, INC.
2 Mar 2018
Director
Sold, plan not stated
15,000
$360.75K
1.4%
EXEL EXELIXIS, INC.
22 Sep 2017
Director
Sold, plan not stated
10,000
$254.00K
100%
EXEL EXELIXIS, INC.
19 Sep 2017
Director
Sold, plan not stated
127,790
$3.53M
11.0%
EXEL EXELIXIS, INC.
18 Sep 2017
Director
Sold, plan not stated
72,210
$2.00M
5.9%
EXEL EXELIXIS, INC.
20 Mar 2017
Director
Sold, plan not stated
10,000
$216.60K
0.8%
BIIB Biogen
27 Jul 2015
Director
Bought
5,000
$1.52M
opened
BIIB Biogen
27 Jul 2015
Director
Bought
5,000
$1.52M
opened
BIIB Biogen
11 Jun 2013
Director
Sold, plan not stated
2,020
$443.63K
13.5%
BIIB Biogen
11 Mar 2013
Director
Sold, plan not stated
46,675
$8.04M
75.7%
EXEL EXELIXIS, INC.
24 Aug 2010
Director
Bought
200,000
$610.20K
21.2%
EXEL EXELIXIS, INC.
30 Oct 2008
Director
Bought
300,000
$968.83K
46.7%
19 decisions on file.